Orifarm Healthcare OÜ
Orifarm Healthcare OÜ is a OÜ based in Tallinn, registry code 16042905, status: active. Main activity: Other business support service activities n.e.c.. According to EMTA, turnover for Q3 2026 was €1 005 335 with 1 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1 mn €above 98% of companiesindustry median 14 701 € · companies in the industry: 1 226
- Labour taxes per employee 13 150 €above 98% of companiesindustry median 1 350 € · companies in the industry: 777
- Revenue · 2024 3.3 mn €above 98% of companiesindustry median 3 141 € · companies in the industry: 3 977
- Net profit margin · 2024 5.3 %above 40% of companiesindustry median 12.8 % · companies in the industry: 2 270
Taxes and turnover
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 005 335 | 11 448 | 13 150 | 1 |
| Q2 2026 | 1 305 741 | 13 745 | 13 457 | 1 |
| Q1 2026 | 1 371 823 | 8 240 | 9 263 | 1 |
| Q4 2025 | 1 564 565 | 8 095 | 8 790 | 1 |
| Q3 2025 | 1 375 503 | 10 623 | 11 963 | 1 |
| Q2 2025 | 1 309 085 | — | 8 430 | 1 |
| Q1 2025 | 1 184 185 | 7 246 | 7 911 | 1 |
| Q4 2024 | 1 298 613 | 7 017 | 7 481 | 1 |
| Q3 2024 | 1 060 766 | 11 479 | 11 396 | 1 |
| Q2 2024 | 1 149 877 | 9 737 | 8 004 | 1 |
| Q1 2024 | 1 101 306 | — | 9 953 | 1 |
| Q4 2023 | 1 228 457 | 21 999 | 5 194 | 1 |
| Q3 2023 | 757 689 | 6 594 | 5 409 | 1 |
| Q2 2023 | 1 034 436 | — | 39 934 | 1 |
| Q1 2023 | 628 305 | 15 841 | 15 269 | 1 |
| Q4 2022 | 2 519 124 | 12 121 | 12 262 | 2 |
| Q3 2022 | 326 227 | 17 868 | 18 138 | 2 |
| Q2 2022 | 313 326 | 14 690 | 13 509 | 2 |
| Q1 2022 | 41 843 | 13 786 | 14 105 | 2 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | — | — | — | — | — | 1 |
| 2024 | 3 313 628 | 175 666 | 75 025 | 1 532 592 | 429 477 | 1 |
| 2023 | 2 701 631 | 113 029 | 144 991 | 746 495 | 253 811 | 2 |
| 2022 | 2 649 705 | 83 341 | 133 241 | 638 260 | 204 782 | 2 |
| 2021 | 1 418 000 | 118 941 | 110 134 | 1 436 544 | 121 441 | 2 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 1 Dec 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 29 May 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 3 Oct 2023 | Company’s own | e-Äriregister |
| 2021 | 2 Sep 2020 – 31 Dec 2021 | 6 Jul 2022 | Company’s own | e-Äriregister |
Board
- Thomas BrandhofBoard member · since 14 May 2024
- Hans Carl Bøgh-SørensenBoard member · since 21 Jul 2025
- Mads Fink EriksenBoard member · since 21 Jul 2025
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- ORIFARM GENERICS HOLDING A/SLegal person · 2 500 €
Beneficial owners
- Andreas Henrik Bøgh-SørensenIndirect ownership · DNK · since 7 Aug 2025
- Anne-Charlotte Bøgh-SørensenIndirect ownership · DNK · since 7 Aug 2025
- Christian Ulrik Bøgh-SørensenIndirect ownership · DNK · since 7 Aug 2025
- Hans Carl Bøgh-SørensenIndirect ownership · DNK · since 7 Aug 2025
Founders and other persons
- Advokaadibüroo Magnusson OÜFounder · 2 500 € · 2 Sep 2020
Activities (EMTAK)
- 82991Other business support service activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50153845 / M3 9 Oct 2026 |
Procedural ruling | 23 Oct 2026 | In force 9 Oct 2026 |
|
| Ä 50153845 / 11 13 Jan 2026 |
Amendment entry | In force 13 Jan 2026 |
||
| Ä 50153845 / 10 9 Sep 2025 |
Entry refused: deficiencies not eliminated | In force 2 Oct 2025 |
||
| Ä 50153845 / M2 12 Aug 2025 |
Ruling to eliminate deficiencies | 5 Sep 2025 | In force 2 Oct 2025 |
|
| Ä 50153845 / 9 21 Jul 2025 |
Amendment entry | In force 21 Jul 2025 |
||
| Ä 50153845 / 8 14 May 2024 |
Amendment entry | In force 14 May 2024 |
||
| Ä 50153845 / 7 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50153845 / 6 3 May 2023 |
Amendment entry | In force 3 May 2023 |
||
| Ä 50153845 / 5 11 Oct 2021 |
Amendment entry | In force 11 Oct 2021 |
||
| Ä 50153845 / 4 22 Aug 2021 |
Amendment entry | In force 22 Aug 2021 |
||
| Ä 50153845 / 3 19 Oct 2020 |
Amendment entry | In force 19 Oct 2020 |
||
| Ä 50153845 / M1 16 Oct 2020 |
Ruling to eliminate deficiencies | 31 Oct 2020 | Deficiencies eliminated 19 Oct 2020 |
|
| Ä 50153845 / 2 7 Oct 2020 |
Amendment entry | In force 7 Oct 2020 |
||
| Ä 50153845 2 Sep 2020 |
First entry | In force 2 Sep 2020 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data